Bortezomib-Based Induction And Maintenance Overcomes The Negative Prognostic Impact Of Renal Impairment And Del17p In Transplant-Eligible Myeloma Patients: Long Term Results From The Phase Iii Hovon-65/Gmmg-Hd4 Study After Median 137 Months Follow Up

BLOOD(2019)

Cited 3|Views85
No score
Abstract
Background:
More
Translated text
Key words
bortezomib-based,transplant-eligible
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined